Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention

The newly proposed term “metabolic dysfunction-associated fatty liver disease” (MAFLD) is replacing the old term “non-alcoholic fatty liver disease” (NAFLD) in many global regions, because it better reflects the pathophysiology and cardiometabolic implications of this common liver disease. The propo...

Full description

Saved in:

Bibliographic Details
Published in:	Cardiovascular diabetology Vol. 21; no. 1; pp. 270 - 17
Main Authors:	Zhou, Xiao-Dong, Cai, Jingjing, Targher, Giovanni, Byrne, Christopher D., Shapiro, Michael D., Sung, Ki-Chul, Somers, Virend K., Chahal, C. Anwar A., George, Jacob, Chen, Li-Li, Zhou, Yong, Zheng, Ming-Hua
Format:	Journal Article
Language:	English
Published:	London BioMed Central 03.12.2022 Springer Nature B.V BMC
Subjects:	Angiology Cardiology Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - diagnosis Cardiovascular Diseases - epidemiology Cardiovascular Diseases - prevention & control Cohort analysis Diabetes Fatty liver Heart attacks Heart Disease Risk Factors Hepatitis Humans Liver diseases Medicine Medicine & Public Health Metabolic dysfunction-associated fatty liver disease (MAFLD) Metabolism Morbidity Mortality Non-alcoholic fatty liver disease (NAFLD) Non-alcoholic Fatty Liver Disease - diagnosis Non-alcoholic Fatty Liver Disease - epidemiology Pharmacotherapies Review Risk Factors Stroke Terminology Pharmacotherapies Metabolic dysfunction-associated fatty liver disease (MAFLD) Cardiovascular disease Risk factors Non-alcoholic fatty liver disease (NAFLD)
ISSN:	1475-2840, 1475-2840
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!